Latest Health Developments: From Bird Flu Concerns to Biotech IPOs

The CDC investigates potential bird flu infections in Washington farm workers. Baxter seeks to restore dialysis patient access post-Hurricane Helene. CVS's new CEO faces challenges at Aetna. Hong Kong zoos battle melioidosis. Sanofi negotiates Opella sale. Legal actions and health studies dominate the news.

In Washington, a potential outbreak of bird flu has prompted the CDC to send a team to investigate the health conditions of farm workers. This follows suspicions that four people may have contracted the virus, marking it as the sixth human outbreak state-wide this year.

Baxter has announced ambitious plans to bring its dialysis service levels back to pre-Hurricane Helene capacity. Restrictions had been incurred to restrict new patients primarily to those under 18, but the company now aims to support children's hospitals with full allocations.

In other news, CVS Health's new CEO faces scrutiny over handling rising medical expenses at its Aetna business. Meanwhile, Sanofi enters talks to sell a controlling stake in its Opella unit, underscoring significant strategic moves within the pharmaceutical industry.

(With inputs from agencies.)